The Scientists Powering Olfactive Biosolutions
From receptor insight to real-world results.
Our Science Team brings together clinical leadership, deep receptor biology expertise, and product-development execution to translate chemosensory and ectopic receptor insights into evidence-backed metabolic health solutions.
Dr. Bill Harries
Chief Scientist
Board member, Hauptman-Woodward Research Institute; membrane protein biochemistry; former chief scientist/cofounder Aromyx; UCSF Stroud Lab.
Dr. Christopher Maclay
Chief Medical Officer
FAARM model; functional/anti-aging/regenerative medicine; metabolic dysfunction strategy.
Brad Brown
Senior Scientist
Former senior scientist and robotics and automation lead, Aromyx. Expertise in assay development, mass spectrometry, automated workflows.
Dr. Sandeepa Dey
Senior Scientist
Former senior scientist, Aromyx. NIH Early Career Award winner, expertise in receptor signaling, numerous olfaction patents.
Chris Hanson
Chief Technology Officer
Built receptor-tech at Aromyx and brings rare olfactory/taste/ectopic receptor + AI depth to turn “food molecules → validated receptor effects” into a repeatable platform.
Science Advisory Board
Our Science Advisory Board brings together world-class experts in chemosensory receptors and human biology—spanning olfactory science, structural and molecular biology, food science and nutrition, cancer signaling, genetics, and AI/ML–driven discovery. The group includes senior academic leaders from institutions such as UCSF, Stanford, Penn State, and UC Davis, alongside seasoned industry innovators in flavor & fragrance, computational drug discovery, and health technology. Together, they help Olfactive Biosolutions translate rigorous receptor biology into validated, product-ready pathways—strengthening our scientific foundation from mechanism through real-world application.
Dr. Andrew Patron
Former Osmo, Firmenich, Senomyx; expert in receptor-based discovery and optimization.
Dr. Robert Stroud
Professor, Biochemistry & Biophysics / Pharmaceutical Chemistry, UCSF.
Dr. Bruce German
Professor & Chemist, Food Science & Technology, UC Davis.
Dr. Danny Dhanasekaran
Professor / Center Director, OU Health Stephenson Cancer Center.
Dr. James Broach
Distinguished Professor & Chair, Biochemistry & Molecular Biology, Penn State.
Dr. Alex Woo
CEO, W2O Food Innovation. Former PepsiCo, Starbucks, Wrigley/Mars, Cargill.
Dr. Madhusudan Patel
Innovation Consultant, former IFF, Henkel, Colgate-Palmolive.
Dr. Tsachy Weissman
Professor, Stanford University School of Engineering. Information theory, AI and ML.
Dr. Tyrone Grandison
CTO App Innovation, Microsoft. Strong background in data science and AI.
Dr. Ronjon Nag
Adjunct Professor of Genetics, Stanford School of Medicine. Longevity and AI expert.
Food molecules → Human receptors → Measurable Physiology
We developed the TruePath® Receptor Platform to identify how food ligands interact with ectopic olfactory, taste and related receptors throughout the body—then translate that biology into formulations like Pivit. Our unique technology demonstrates how ectopic receptors often perform the same physiologic tasks as active pharmaceutical ingredients or APIs, and what ligands activate or inhibit them. These ligands can often be food molecules that humans have been ingesting for long periods of time:
- Ectopic OR/TR receptors exist throughout the body and participate in processes including glucose and lipid metabolism.
- TruePath combines receptor technology, assays, automation, and receptor-trained AI to screen ligands efficiently.
- Pivit is commercialized DTC as a supplement and also as an ingredient / licensing opportunity.
Olfactory (OR) and taste receptors (TR) are classically known for smell and taste—but the same receptor families are found throughout the body as ectopic receptors.
These ectopic receptors can regulate metabolic events such as insulin secretion, glucagon secretion, fatty acid oxidation, lipogenesis, and thermogenesis.
Our proprietary TruePath ligand-receptor discovery platform represents world-leading receptor technology, comprising proprietary cell lines, DNA sequences, plasmids, protein expression techniques, cellular assays, liquid handling robots, and AI-powered analysis software.